Trial · NCT01205776
EXCEL Clinical Trial
NCT01205776, Not applicable, Completed, Abbott Medical Devices; results first posted 2018-03-29
3 sourcestrials-2026-11-12-0.5.0
Download JSON
Cite this record
ConductScience Library. EXCEL Clinical Trial. Trials, record NCT01205776. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT01205776
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- EXCEL Clinical Trial
- NCT number
- NCT01205776
- Status
- Completed
- Phases
- Not applicable
- Enrollment
- 1,905 participants, actual
- Lead sponsor
- Abbott Medical Devices
- Conditions
Chronic Coronary Occlusion, Unprotected Left Main Coronary Artery Disease, Stent Thrombosis, Vascular Disease, Myocardial Ischemia, Coronary Artery Stenosis, Coronary Disease, Coronary Artery Disease, Coronary Restenosis
- Interventions
- Percutaneous Coronary Intervention, CABG
- First posted
- 2010-09-20
- Last updated
- 2020-04-07
- Results first posted
- 2018-03-29
Source ClinicalTrials.gov
Registered outcomes92
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Number of Participants With All-cause Death, Protocol Defined MI or Protocol Defined Stroke | 5 years | All deaths includes Cardiac death, Vascular death and Non-cardiovascular death. Myocardial Infarction (MI): * Q wave MI: Development of new, pathological Q wave on the ECG. * Non-Q wave MI: Elevation of CK levels to ≥ two times the upper limit of normal (ULN) with elevated CK-MB in the absence of new pathological Q waves. Stroke is defined as the rapid onset of a new persistent neurologic deficit attributed to an obstruction in cerebral blood flow and/or cerebral hemorrhage with no apparent non-vascular cause (e.g., trauma, tumor, or infection). |
| Secondary | Number of Participants With All-cause Death, Protocol Defined MI or Protocol Defined Stroke | In-hospital (≤ 7 days of index-procedure) | All deaths includes Cardiac death, Vascular death and Non-cardiovascular death. Myocardial Infarction (MI): * Q wave MI: Development of new, pathological Q wave on the ECG. * Non-Q wave MI: Elevation of CK levels to ≥ two times the upper limit of normal (ULN) with elevated CK-MB in the absence of new pathological Q waves. Stroke is defined as the rapid onset of a new persistent neurologic deficit attributed to an obstruction in cerebral blood flow and/or cerebral hemorrhage with no apparent non-vascular cause (e.g., trauma, tumor, or infection). |
| Secondary | Number of Participants With All-cause Death, Protocol Defined MI or Protocol Defined Stroke | 30 days | All deaths includes Cardiac death, Vascular death and Non-cardiovascular death. Myocardial Infarction (MI): * Q wave MI: Development of new, pathological Q wave on the ECG. * Non-Q wave MI: Elevation of CK levels to ≥ two times the upper limit of normal (ULN) with elevated CK-MB in the absence of new pathological Q waves. Stroke is defined as the rapid onset of a new persistent neurologic deficit attributed to an obstruction in cerebral blood flow and/or cerebral hemorrhage with no apparent non-vascular cause (e.g., trauma, tumor, or infection). |
| Secondary | Number of Participants With All-cause Death, Protocol Defined MI or Protocol Defined Stroke | 0 to 6 months | All deaths includes Cardiac death, Vascular death and Non-cardiovascular death. Myocardial Infarction (MI): * Q wave MI: Development of new, pathological Q wave on the ECG. * Non-Q wave MI: Elevation of CK levels to ≥ two times the upper limit of normal (ULN) with elevated CK-MB in the absence of new pathological Q waves. Stroke is defined as the rapid onset of a new persistent neurologic deficit attributed to an obstruction in cerebral blood flow and/or cerebral hemorrhage with no apparent non-vascular cause (e.g., trauma, tumor, or infection). |
| Secondary | Number of Participants With All-cause Death, Protocol Defined MI or Protocol Defined Stroke | 0 to 1 year | All deaths includes Cardiac death, Vascular death and Non-cardiovascular death. Myocardial Infarction (MI): * Q wave MI: Development of new, pathological Q wave on the ECG. * Non-Q wave MI: Elevation of CK levels to ≥ two times the upper limit of normal (ULN) with elevated CK-MB in the absence of new pathological Q waves. Stroke is defined as the rapid onset of a new persistent neurologic deficit attributed to an obstruction in cerebral blood flow and/or cerebral hemorrhage with no apparent non-vascular cause (e.g., trauma, tumor, or infection). |
| Secondary | Number of Participants With All-cause Death, Protocol Defined MI or Protocol Defined Stroke | 0 to 2 years | All deaths includes Cardiac death, Vascular death and Non-cardiovascular death. Myocardial Infarction (MI): * Q wave MI: Development of new, pathological Q wave on the ECG. * Non-Q wave MI: Elevation of CK levels to ≥ two times the upper limit of normal (ULN) with elevated CK-MB in the absence of new pathological Q waves. Stroke is defined as the rapid onset of a new persistent neurologic deficit attributed to an obstruction in cerebral blood flow and/or cerebral hemorrhage with no apparent non-vascular cause (e.g., trauma, tumor, or infection). |
| Secondary | Number of Participants With All-cause Death, Protocol Defined MI or Protocol Defined Stroke | 0 to 3 years | All deaths includes Cardiac death, Vascular death and Non-cardiovascular death. Myocardial Infarction (MI): * Q wave MI: Development of new, pathological Q wave on the ECG. * Non-Q wave MI: Elevation of CK levels to ≥ two times the upper limit of normal (ULN) with elevated CK-MB in the absence of new pathological Q waves. Stroke is defined as the rapid onset of a new persistent neurologic deficit attributed to an obstruction in cerebral blood flow and/or cerebral hemorrhage with no apparent non-vascular cause (e.g., trauma, tumor, or infection). |
| Secondary | Number of Participants With All-cause Death, Protocol Defined MI or Protocol Defined Stroke | 0 to 4 years | All deaths includes Cardiac death, Vascular death and Non-cardiovascular death. Myocardial Infarction (MI): * Q wave MI: Development of new, pathological Q wave on the ECG. * Non-Q wave MI: Elevation of CK levels to ≥ two times the upper limit of normal (ULN) with elevated CK-MB in the absence of new pathological Q waves. Stroke is defined as the rapid onset of a new persistent neurologic deficit attributed to an obstruction in cerebral blood flow and/or cerebral hemorrhage with no apparent non-vascular cause (e.g., trauma, tumor, or infection). |
| Secondary | Number of Participants With All-cause Death, Protocol Defined MI or Protocol Defined Stroke | 0 to 5 years | All deaths includes Cardiac death, Vascular death and Non-cardiovascular death. Myocardial Infarction (MI): * Q wave MI: Development of new, pathological Q wave on the ECG. * Non-Q wave MI: Elevation of CK levels to ≥ two times the upper limit of normal (ULN) with elevated CK-MB in the absence of new pathological Q waves. Stroke is defined as the rapid onset of a new persistent neurologic deficit attributed to an obstruction in cerebral blood flow and/or cerebral hemorrhage with no apparent non-vascular cause (e.g., trauma, tumor, or infection). |
| Secondary | Number of Participants With Death, Protocol Defined MI, Protocol Defined Stroke or Unplanned Revascularization for Ischemia | In-hospital (≤ 7 days of index-procedure) | All deaths includes Cardiac death, Vascular death and Non-cardiovascular death. Myocardial Infarction (MI): * Q wave MI: Development of new, pathological Q wave on the ECG. * Non-Q wave MI: Elevation of CK levels to ≥ two times the upper limit of normal (ULN) with elevated CK-MB in the absence of new pathological Q waves. Stroke is defined as the rapid onset of a new persistent neurologic deficit attributed to an obstruction in cerebral blood flow and/or cerebral hemorrhage with no apparent non-vascular cause (e.g., trauma, tumor, or infection). |
1 to 10 of 92Source ClinicalTrials.gov
See all 92 registered outcomesOutcomes92
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
| Type | Outcome | Time frame | Population | Units | Measured as |
|---|---|---|---|---|---|
| PRIMARY | Number of Participants With All-cause Death, Protocol Defined MI or Protocol Defined Stroke | 5 years | Participants | COUNT_OF_PARTICIPANTS | |
| SECONDARY | Number of Participants With All-cause Death, Protocol Defined MI or Protocol Defined Stroke | In-hospital (≤ 7 days of index-procedure) | ITT population. Subjects without the required follow-up are excluded from the time period. | Participants | COUNT_OF_PARTICIPANTS |
| SECONDARY | Number of Participants With All-cause Death, Protocol Defined MI or Protocol Defined Stroke | 30 days | Participants | COUNT_OF_PARTICIPANTS | |
| SECONDARY | Number of Participants With All-cause Death, Protocol Defined MI or Protocol Defined Stroke | 0 to 6 months | ITT population. | Participants | COUNT_OF_PARTICIPANTS |
| SECONDARY | Number of Participants With All-cause Death, Protocol Defined MI or Protocol Defined Stroke | 0 to 1 year | ITT population. | Participants | COUNT_OF_PARTICIPANTS |
| SECONDARY | Number of Participants With All-cause Death, Protocol Defined MI or Protocol Defined Stroke | 0 to 2 years | ITT population. | Participants | COUNT_OF_PARTICIPANTS |
| SECONDARY | Number of Participants With All-cause Death, Protocol Defined MI or Protocol Defined Stroke | 0 to 3 years | ITT population. | Participants | COUNT_OF_PARTICIPANTS |
| SECONDARY | Number of Participants With All-cause Death, Protocol Defined MI or Protocol Defined Stroke | 0 to 4 years | ITT population | Participants | COUNT_OF_PARTICIPANTS |
| SECONDARY | Number of Participants With All-cause Death, Protocol Defined MI or Protocol Defined Stroke | 0 to 5 years | ITT population | Participants | COUNT_OF_PARTICIPANTS |
| SECONDARY | Number of Participants With Death, Protocol Defined MI, Protocol Defined Stroke or Unplanned Revascularization for Ischemia | In-hospital (≤ 7 days of index-procedure) | ITT population. Subjects without the required follow-up are excluded from the time period. | Participants | COUNT_OF_PARTICIPANTS |
1 to 10 of 92Source ClinicalTrials.gov
See all 92 outcomesResults by group242
Each measurement the trial posted, group by group, in the words and numbers it posted.
| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Number of Participants With All-cause Death, Protocol Defined MI or Protocol Defined Stroke | Percutaneous Coronary Intervention (PCI) | 203 | Participants | ||
| Number of Participants With All-cause Death, Protocol Defined MI or Protocol Defined Stroke | Coronary Artery Bypass Graft (CABG) | 176 | Participants | ||
| Number of Participants With All-cause Death, Protocol Defined MI or Protocol Defined Stroke | Percutaneous Coronary Intervention (PCI) | 40 | Participants | ||
| Number of Participants With All-cause Death, Protocol Defined MI or Protocol Defined Stroke | Coronary Artery Bypass Graft (CABG) | 77 | Participants | ||
| Number of Participants With All-cause Death, Protocol Defined MI or Protocol Defined Stroke | Percutaneous Coronary Intervention (PCI) | 46 | Participants | ||
| Number of Participants With All-cause Death, Protocol Defined MI or Protocol Defined Stroke | Coronary Artery Bypass Graft (CABG) | 75 | Participants | ||
| Number of Participants With All-cause Death, Protocol Defined MI or Protocol Defined Stroke | Percutaneous Coronary Intervention (PCI) | 66 | Participants | ||
| Number of Participants With All-cause Death, Protocol Defined MI or Protocol Defined Stroke | Coronary Artery Bypass Graft (CABG) | 97 | Participants | ||
| Number of Participants With All-cause Death, Protocol Defined MI or Protocol Defined Stroke | Percutaneous Coronary Intervention (PCI) | 80 | Participants | ||
| Number of Participants With All-cause Death, Protocol Defined MI or Protocol Defined Stroke | Coronary Artery Bypass Graft (CABG) | 106 | Participants |
1 to 10 of 242Source ClinicalTrials.gov
See all 242 results by groupParticipant flow6
How many started, completed or left each group, period by period.
| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Overall Study | STARTED | Percutaneous Coronary Intervention (PCI) | 948 | |
| Overall Study | STARTED | Coronary Artery Bypass Graft (CABG) | 957 | |
| Overall Study | COMPLETED | Percutaneous Coronary Intervention (PCI) | 884 | |
| Overall Study | COMPLETED | Coronary Artery Bypass Graft (CABG) | 862 | |
| Overall Study | NOT COMPLETED | Percutaneous Coronary Intervention (PCI) | 64 | |
| Overall Study | NOT COMPLETED | Coronary Artery Bypass Graft (CABG) | 95 |
Source ClinicalTrials.gov
Adverse events734
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Anemia | Blood and lymphatic system disorders | Percutaneous Coronary Intervention (PCI) | 42 | 948 | |
| other | Anemia | Blood and lymphatic system disorders | Coronary Artery Bypass Graft (CABG) | 83 | 957 | |
| other | Bleeding | Blood and lymphatic system disorders | Percutaneous Coronary Intervention (PCI) | 75 | 948 | |
| other | Bleeding | Blood and lymphatic system disorders | Coronary Artery Bypass Graft (CABG) | 121 | 957 | |
| other | Coagulopathy | Blood and lymphatic system disorders | Percutaneous Coronary Intervention (PCI) | 1 | 948 | |
| other | Coagulopathy | Blood and lymphatic system disorders | Coronary Artery Bypass Graft (CABG) | 2 | 957 | |
| other | Epistaxis | Blood and lymphatic system disorders | Percutaneous Coronary Intervention (PCI) | 10 | 948 | |
| other | Epistaxis | Blood and lymphatic system disorders | Coronary Artery Bypass Graft (CABG) | 7 | 957 | |
| other | Gastrointestinal bleeding | Blood and lymphatic system disorders | Percutaneous Coronary Intervention (PCI) | 36 | 948 | |
| other | Gastrointestinal bleeding | Blood and lymphatic system disorders | Coronary Artery Bypass Graft (CABG) | 15 | 957 |
1 to 10 of 734Source ClinicalTrials.gov
See all 734 adverse eventsAdverse event totals6
The totals the trial posted for each group.
| Total | Group | Affected | At risk |
|---|---|---|---|
| Total, all-cause mortality | Percutaneous Coronary Intervention (PCI) | 119 | 948 |
| Total, all-cause mortality | Coronary Artery Bypass Graft (CABG) | 89 | 957 |
| Total, other adverse events | Percutaneous Coronary Intervention (PCI) | 791 | 948 |
| Total, other adverse events | Coronary Artery Bypass Graft (CABG) | 831 | 957 |
| Total, serious adverse events | Percutaneous Coronary Intervention (PCI) | 535 | 948 |
| Total, serious adverse events | Coronary Artery Bypass Graft (CABG) | 550 | 957 |
Source ClinicalTrials.gov
Papers25
The papers the trial lists on ClinicalTrials.gov.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons87
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
| Comparison | Source |
|---|---|
| Percutaneous Coronary Intervention (PCI) vs Coronary Artery Bypass Graft (CABG): Number of Participants With All-cause Death, Protocol Defined MI or Protocol Defined Stroke | Trial comparisons |
| Percutaneous Coronary Intervention (PCI) vs Coronary Artery Bypass Graft (CABG): Number of Participants With Bleeding Academic Research Consortium (BARC) Bleeding | Trial comparisons |
| Percutaneous Coronary Intervention (PCI) vs Coronary Artery Bypass Graft (CABG): Number of Participants With All-cause Mortality (Cardiac Death and Non-cardiac Death) | Trial comparisons |
| Percutaneous Coronary Intervention (PCI) vs Coronary Artery Bypass Graft (CABG): Number of Participants With Bleeding Academic Research Consortium (BARC) Bleeding | Trial comparisons |
| Percutaneous Coronary Intervention (PCI) vs Coronary Artery Bypass Graft (CABG): Number of Participants With Definite Stent Thrombosis or Symptomatic Graft Occlusion | Trial comparisons |
| Percutaneous Coronary Intervention (PCI) vs Coronary Artery Bypass Graft (CABG): Number of Participants With Ischemia Driven Revascularizations | Trial comparisons |
| Percutaneous Coronary Intervention (PCI) vs Coronary Artery Bypass Graft (CABG): Number of Participants With Ischemia Driven Revascularizations (TLR,TVR and Non-TVR) | Trial comparisons |
| Percutaneous Coronary Intervention (PCI) vs Coronary Artery Bypass Graft (CABG): Number of Participants With All Revascularizations (Ischemia Driven and Not Ischemia Driven) | Trial comparisons |
| Percutaneous Coronary Intervention (PCI) vs Coronary Artery Bypass Graft (CABG): Number of Participants With Protocol Defined MI | Trial comparisons |
Percutaneous Coronary Intervention (PCI) vs Coronary Artery Bypass Graft (CABG): Number of Participants With Death, Protocol Defined MI, Protocol Defined Stroke or Unplanned Revascularization for Ischemia | Trial comparisons |
1 to 10 of 87
See all 87 trial comparisonsTests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT01205776
GET https://conductscience.org/api/trials/v1/NCT01205776/registered?page=2